# Kyan Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kyan-health

- Industry: Healthcare IT
- Headquarters: Zollikon, Switzerland
- Website: www.kyanhealth.com/
- Total disclosed funding: $13M
- Latest round: Series A (Nov 6, 2024)
- Investors on record: 6

## About

Based in Zollikon, Switzerland, and founded in 2021 by co-founders Vlad Gheorghiu (CEO), Konstantin Struck, and Ignacio Leonhard, Kyan Health AG operates as a provider of AI-driven mental health and well-being solutions, offering personalized support, training programs, and data insights to improve organizational and employee well-being across various industries. In November 2024, Kyan Health AG raised USD 12.7 million in Series A funding led by Swisscom Ventures, with participation from Founderful, naturalX Health Ventures, GreyMatter, and Joyance Partners.

Kyan Health provides a comprehensive workplace wellness and mental health solution intended to improve employee mental well-being through an AI-driven platform. Core offerings include a counseling platform that connects users with a global network of psychologists and coaches, offering support in over 30 languages. Additionally, Kyan Health offers resources such as workshops and training programs intended to empower leadership in organizations, foster resilience, and support a culture of well-being. Services are tailored to address the specific goals of organizations, providing personalized care through data-driven insights. Kyan Health serves clients across various industries, primarily in European and North American markets, focusing on employee mental health and productivity.

Kyan Health generates revenue through subscription-based models, where organizations pay for access to its mental health resources and services. This includes counseling, training, and analytics features. Subscription tiers are structured to meet the needs of organizations of varying sizes, providing flexible options for both large enterprises and smaller businesses.

The company plans to use these funds to expand into new geographic regions, specifically the Asian market, by the end of 2024, with a focus on increasing its client base and service offerings.

## Funding rounds

- Series A, Nov 6, 2024, $13M — Swisscom Ventures, Joyance Partners, Founderful, GreyMatter, naturalX Health Ventures
- Seed, date not disclosed — Amplo

## Investors

- Amplo (https://capitalatlas.ai/funds/amplo) — Seed
- Swisscom Ventures (https://capitalatlas.ai/funds/swisscom-ventures) — Series A
- Joyance Partners (https://capitalatlas.ai/funds/joyance-partners) — Series A
- Founderful (https://capitalatlas.ai/funds/founderful) — Series A
- GreyMatter (https://capitalatlas.ai/funds/greymatter) — Series A
- naturalX Health Ventures (https://capitalatlas.ai/funds/naturalx-health-ventures) — Series A